Importer of Controlled Substances Registration: Johnson Matthey, Inc., 46322 [2015-19107]

Download as PDF 46322 Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices Issued: July 29, 2015. Lisa R. Barton, Secretary to the Commission. Controlled substance Poppy Straw Concentrate (9670) Fentanyl (9801) ............................ [FR Doc. 2015–18984 Filed 8–3–15; 8:45 am] Schedule II II BILLING CODE 7020–02–P The company plans to import thebaine derivatives and fentanyl as reference standards. The company plans to import the remaining listed controlled substances as raw materials, to be used in the manufacture of bulk controlled substances, for distribution to its customers. DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration: Johnson Matthey, Inc. ACTION: Notice of registration. Johnson Matthey, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc., registration as an importer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and published in the Federal Register on April 22, 2015, 80 FR 22559, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742 applied to be registered as an importer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Johnson Matthey, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the basic classes controlled substances: tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: Controlled substance Schedule Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. VerDate Sep<11>2014 18:45 Aug 03, 2015 II II II II Jkt 235001 Dated: July 29, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015–19107 Filed 8–3–15; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. 15–15] Adeline Davies Essien, M.D.; Decision and Order On March 25, 2015, Administrative Law Judge (ALJ) Christopher B. McNeil issued the attached Recommended Decision. Neither party filed exceptions to the Recommended Decision. Having reviewed the record in its entirety, I adopt the ALJ’s findings of fact, conclusions of law and recommended order.1 Accordingly, I will order that Respondent’s DEA Certificate of Registration be revoked and that any pending application to renew or modify her registration be denied. Order Pursuant to the authority vested in me by 21 U.S.C. 823(f) and 824(a)(3), as well as 28 CFR 0.100(b), I order that DEA Certificate of Registration BE6969541, issued to Adeline Davies Essien, M.D., be, and it hereby is, revoked. I further order that any pending application of Adeline Davies Essien, M.D., to renew or modify her registration, be, and it hereby is, denied. This Order is effective September 3, 2015. 1 I take official notice of the fact that, according to the registration records of the Agency, Respondent retains an active registration as of this date. Pursuant to 21 CFR 1316.59(e), Respondent may controvert this finding by filing a properly supported motion, no later than 10 days from the date of this Order. PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 Dated: July 27, 2015. Chuck Rosenberg, Acting Administrator. Frank W. Mann, Esq., for the Government. Thomas P. O’Connell, Esq., for the Respondent. ORDER GRANTING THE GOVERNMENT’S MOTION FOR SUMMARY DISPOSITION and FINDINGS OF FACT, CONCLUSIONS OF LAW, AND RECOMMENDED DECISION OF THE ADMINISTRATIVE LAW JUDGE Administrative Law Judge Christopher B. McNeil. On January 21, 2015, the Deputy Assistant Administrator of the Drug Enforcement Administration (DEA) issued an Order to Show Cause as to why the DEA should not revoke DEA Certificate of Registration Number BE6969541 issued to Adeline Davies Essien, M.D., the Respondent in this matter. The Order seeks to revoke Respondent’s registration pursuant to 21 U.S.C. 824(a)(4) and 823(f), and to deny any pending applications for renewal or modification of such registration, and deny any applications for any new DEA registrations pursuant to 21 U.S.C. 823(f). As grounds for denial, the Government alleges that Respondent is ‘‘currently without authority to handle controlled substances in the State of Illinois, the state in which [Respondent is] registered with the DEA.’’ On February 27, 2015, the DEA’s Office of Administrative Law Judges received Respondent’s written request for a hearing, which is dated February 26, 2015. Respondent stated that she objected to the Government’s allegation regarding Respondent’s authority to handle controlled substances. Respondent further stated that she ‘‘does have authority to practice medicine and handle controlled substances.’’ On March 3, 2015, this Office issued an Order for Briefing on Allegations Concerning Respondent’s Lack of State Authority, Order for Prehearing Statements, and Order Setting the Matter for Hearing. In the Order, I mandated that the parties provide briefs regarding the allegation that Respondent lacks state authority to handle controlled substances no later than 2:00 p.m. on March 17, 2015. In my Order, I also provided that responses to any briefs be submitted by no later than 2:00 p.m. on March 24, 2015. On March 17, 2015, I timely received the Government’s Response to Order and Motion for Summary Disposition. According to the Government’s motion, E:\FR\FM\04AUN1.SGM 04AUN1

Agencies

[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Page 46322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19107]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Johnson Matthey, 
Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey, Inc. applied to be registered as an importer 
of certain basic classes of controlled substances. The Drug Enforcement 
Administration (DEA) grants Johnson Matthey, Inc., registration as an 
importer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015, 80 FR 22559, 
Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West 
Deptford, New Jersey 08066-1742 applied to be registered as an importer 
of certain basic classes of controlled substances. No comments or 
objections were submitted for this notice. Comments and requests for 
hearings on applications to import narcotic raw material are not 
appropriate. 72 FR 3417, (January 25, 2007).
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Johnson Matthey, Inc. to 
import the basic classes of controlled substances is consistent with 
the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated the company's maintenance of effective 
controls against diversion by inspecting and testing the company's 
physical security systems, verifying the company's compliance with 
state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of the basic classes controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Coca Leaves (9040).........................  II
Thebaine (9333)............................  II
Opium, raw (9600)..........................  II
Noroxymorphone (9668)......................  II
Poppy Straw Concentrate (9670).............  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import thebaine derivatives and fentanyl as 
reference standards.
    The company plans to import the remaining listed controlled 
substances as raw materials, to be used in the manufacture of bulk 
controlled substances, for distribution to its customers.

    Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19107 Filed 8-3-15; 8:45 am]
BILLING CODE 4410-09-P